2016 section

IMB researchers in the world’s top 1% for impact

16 December 2016 | Four IMB researchers have been recognised as some of the world’s most influential scientific minds, as measured by the Thomson Reuters Highly Cited Researchers list.

$10M boost for IMB’s health and medical research

5 December 2016 | IMB researchers have received funding for seven NHMRC Project Grants totalling $5.1 million to improve our understanding of—and future treatments for—heart disease, pain, cancer, infection, and type 2 diabetes.

Top women in science ready to tackle voyage of lifetime

1 December 2016 | IMB Industry Fellow Dr Christina Schroeder will tomorrow set sail for the inaugural Homeward Bound program, which is the largest-ever female expedition to Antarctica. The program aims to help women in science to develop their skills in leadership and strategy and raise awareness of the important contributions made by women in STEMM fields. Story via Quest Community Newspapers.

Young immunologist awarded for impact

17 November 2016 | The young inventor behind a University of Queensland discovery that could benefit patients living with inflammatory diseases has been awarded the 2016 Research Australia Discovery Award. IMB early career researcher Dr Rebecca Coll received her award at last night’s Research Australia Health and Medical Research Awards ceremony in Sydney for her work in identifying promising anti-inflammatory compounds that block the NLRP3 inflammasome — a key driver of inflammation.

Revolutionary advances in microscopy provide an opportunity to break a roadblock in cancer research

14 November 2016 | A $2.3M grant from Australian Cancer Research Foundation (ACRF) is being awarded to The University of Queensland’s Institute for Molecular Bioscience (IMB) today to establish the new ACRF Cancer Ultrastructure and Function Facility (CUFF). The nation-leading facility will provide cutting-edge imaging capabilities for tracking and visualising cancer.

Talking science, sport and superbugs during Antibiotic Awareness Week

14 November 2016 | Superbug-infested waters posed a major health threat to sporting superstars at this year's Rio Olympic Games. But what did this mean for athletes as they competed? And how will it affect their future health and performance? Brisbane-based sport and science experts will discuss these questions and more during Superbugs at the Olympics on Thursday night (17 November). The IMB Centre for Superbug Solutions is hosting the free community event during Antibiotic Awareness Week.

IMB researchers awarded top prizes at Brisbane’s 2016 HealthHack

9 November 2016 | Researchers from IMB have won first and third prize at Brisbane’s 2016 HealthHack, held 14-16 October at River City Labs. The winning team, Superfriends Against Superbugs, developed an app to track and map the presence of antibiotic-resistant bacteria and rapidly alert clinicians, so they can limit the spread of bacteria and fight an outbreak in real-time.

Register for Superbugs at the Olympics

17 November 2016 | Register now for this free community event! Drug-resistant bacteria, or superbugs, are one of greatest challenges currently facing global human health. Superbug-infested waters surrounded the Olympic Games in Rio this year. What did this mean for our athletes? Join a panel of Olympians and scientific experts to discuss the issue.

An ugly menace

7 November 2016 | In a world-first, UQ’s Professor Rob Capon and his team are working with industry and the community to implement a discovery that turns cane toads’ own toxin against them, with real potential to eradicate this long-term pest. (Via UQ Research Impact)

So long, superbugs – crowdsourcing is here

7 November 2016 | By creating the world’s first molecule bank, UQ scientists are working with industry and institutional partners to crowdsource antibiotic compounds, aiming to seek out new antibiotics and prevent the proliferation of drug-resistant superbugs. (Via UQ Research Impact)

Discoveries inspired by life

7 November 2016 | INSTITUTE IN FOCUS: Read how the natural world is inspiring researchers at the Institute for Molecular Bioscience (IMB) to develop treatments for disease and solutions for agricultural and environmental issues. (Via UQ ChangeMakers magazine)

Funding for a tumour-free future

2 November 2016 | A future where no children suffer deadly brain tumours may be within reach, thanks to the vision of a team of researchers from UQ and generous funding from The Kids’ Cancer Project. This funding will enable IMB postdoctoral researcher Dr Laura Genovesi to develop better treatments – and eventually cures – for these devastating conditions.

$4.5 million for IMB-led discovery research

1 November 2016 | IMB researchers have been awarded $4.5 million by the Australian Research Council to lead a range of groundbreaking discovery research projects. The ARC announced funding of more than $37 million today for UQ projects spanning fields as diverse as humanities, behavioural science, biomedicine and frontier technologies.

UQ medical research recognised on national stage

31 October 2016 | Two companies founded on UQ research have won acclaim at the National AusBiotech Conference in Melbourne. The AusBiotech and Johnson & Johnson’s Innovation Industry Excellence Awards have recognised Protagonist Therapeutics as Australian Company of the Year and ResApp Health as the Australian Emerging Company of the Year. Protagonist Therapeutics, a clinical-stage biopharmaceutical company, is developing oral drugs for the treatment of gastrointestinal disorders such as Inflammatory Bowel Disease. The work is founded on research from UQ’s Institute for Molecular Bioscience (IMB).

Being number one is in UQ’s nature

27 October 2016 | High-quality research from UQ is helping drive the nation’s success in a prestigious rankings system. UQ has been confirmed as the top institute in Australia in the Nature Index 2016 Australia and New Zealand, released today.

IMB Seminar Series - A molecular movie of the Excitation-Contraction Coupling

24 October 2016 | Please join us on Friday 4 November 2016 from 12 noon for our IMB Seminar Series with international early career scientist Prof Nieng Yan, who combines structural biology, biochemistry, and molecular biophysics to investigate the mechanisms of substrate recognition and transport, as well as electrochemical-–mechanical coupling of membrane transport proteins.

Medicine will grow on trees at UQ

18 October 2016 | The future of medicine could be as simple as nibbling a sunflower seed or drinking a cup of tea, with the opening of a new facility at The University of Queensland on 18 October. The Clive and Vera Ramaciotti Facility for Producing Pharmaceuticals in Plants at UQ’s Institute for Molecular Bioscience has the potential to provide inexpensive medications to patients, which will have a significant impact locally and internationally.

IMB Seminar Series – Controlling light to understand and drive nanoscale processes

24 October 2016 | Deputy Vice Chancellor Research and Innovation at the University of South Australia, Professor Tanya Monro, will provide insight into research within the ARC Centre of Excellence in Nanoscale Biophotonics. Professor Monro has received numerous awards including the Eureka Prize for Excellence in Interdisciplinary Scientific Research, the Bragg Gold Medal (Best Physics PhD in Australia) and South Australia’s “Australian of the Year”. The seminar will be held on Monday 24 October from 12pm-1pm in the Queensland Bioscience Precinct (Building 80) auditorium, UQ St Lucia.

Major advance in designer drug development

14 October 2016 | In a world-first, researchers from UQ IMB and University of Washington (UW) have produced tailor-made peptides – an advance expected to help improve drug design and environmentally-friendly pesticides. The team has designed ultra-stable peptide scaffolds that can be used in a range of biotechnological applications.

Swipe and spit for postpartum depression

28 September 2016 | Does genetic susceptibility predispose women to postpartum depression? Researchers from The University of Queensland are calling on Australian mothers to help them find out. UQ Institute for Molecular Bioscience researcher Professor Naomi Wray and her team are seeking to study 2,000 Australian mothers who have experienced postpartum depression.

Funding to grow bionic hearts

21 September 2016 | In an IMB laboratory, human heart cells grown from stem cells can be seen without the aid of a microscope beating in a petri dish. In the future, these new heart cells could be transplanted into patients with heart disease to replace damaged sections of their hearts.

Paralympian highlights the importance of antibiotic research

13 September 2016 | Paralympian Chris Bond was 19 when a severe bacterial infection in his bowel spread through his body and sent him into septic shock. Today, on World Sepsis Day (13 September), Chris is working with the Community for Open Antimicrobial Drug Discovery (CO-ADD), based at The University of Queensland, to bring attention to the multidrug-resistant bacteria that nearly took his life.

UQ’s work on inflammatory disease treatment wins $22m global investment

12 September 2016 | Inflazome Ltd, a company founded on research from the Institute for Molecular Bioscience and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million). The investment, co-led by two top global life science investment firms, is one of the largest biotech Series A investments for intellectual property originating from an Australian university.

IMB researcher wins European Peptide Society award

27 September 2016 | Congratulations to IMB’s Dr Markus Muttenthaler who received the Miklós Bodanszky Award for his outstanding contributions to peptide science. The award is given to early career researchers who have made significant contributions to peptide-based drug research.

InfoTech professional wins Women in Technology Award

2 September 2016 | IMB’s Mathilde Desselle has won the Queensland Women in Technology (WiT) InfoTech Professional Award for her leadership of biomedical research programs and facilities. Mathilde is the program coordinator for the global, award-winning, multi-million dollar antibiotics discovery program the Community for Open Antimicrobial Drug Discovery (CO-ADD) at the IMB Centre for Superbug Solutions.

IMB Seminar Series - Revealing the molecular world through biomedical animation

30 August 2016 | Please join us on Friday 23 September 2016 from 12.30pm for our IMB Seminar Series with world-renowned biomedical animator Dr Drew Berry who will discuss how he combines cinema and science to reveal the microscopic worlds inside our bodies.

Breakthrough in understanding Parkinson’s disease

Research from UQ could lead to a new treatment for Parkinson’s disease, with future potential applications to nearly 50 other disorders. In Parkinson's disease – which affects about eight million people worldwide – vital nerve cells (neurons) in the brain malfunction or die. Researchers IMB examined a genetic mutation that interrupts the traffic of materials within neurons and allows waste products to accumulate, causing Parkinson’s disease.

Bacterial or viral? Now we can tell

26 August 2016 | Researchers from IMB and Imperial College London have developed a method to distinguish viral and bacterial infections in children, which will save lives and reduce antibiotic use. Associate Professor Lachlan Coin from the Centre for Superbug Solutions at UQ’s Institute for Molecular Bioscience said bacterial and viral infections could be difficult to tell apart. The team's new method will prevent the unnecessary prescription of antibiotics to children with viral infections, and ensure dangerous bacterial infections don’t go undetected.

Mobile phone diagnostic tool to help detect disease

23 August 2016 | Thanks to funding from the Bill & Melinda Gates Foundation, IMB Group Leader Professor Kirill Alexandrov will pursue an innovative global health and development research project to repurpose glucose monitoring technology to develop a cheap, portable biosensor to detect a range of infectious diseases, including Dengue fever and Zika virus.

Biotech one step closer to bowel disease treatment

22 August 2016 | IMB spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide. The company is headquartered in California with research operations at UQ’s Institute for Molecular Bioscience in Brisbane. It is working on the development of peptide-based oral drugs to treat inflammatory bowel disease including Crohn’s disease and ulcerative colitis.

UQ medical research recognised as some of nation’s best

19 August 2016 | The National Health and Medical Research Council has named two UQ projects among its 10 of the Best Research Projects 2015, including IMB Group Leader Professor David Craik's project named “The scorpion king: lighting the way to defeating brain cancer”. These projects have led to ground-breaking medical discoveries and important changes to healthcare.

3rd Annual Queensland Forum on Antimicrobial Resistance

17 August 2016 | Please join us on 14 November for this important forum, which will gather experts from both the clinical and scientific community to focus on a One Health approach to combat antimicrobial resistance. Register now!

Apply now for the IMB Research Advancement Award

3 August 2016 | Applications are now open for the IMB Research Advancement Award, offering brilliant prospective PhD students the opportunity to secure a $30,000 top-up scholarship to support their studies at IMB.

New group leaders to join IMB’s fight against disease

2 August 2016 | IMB has welcomed three new research groups to bolster its investigations into neurological and psychiatric disorders, including motor neuron disease, Parkinson’s disease, dementia, autism and schizophrenia. Professor Peter Visscher, Professor Naomi Wray and Associate Professor Jian Yang –– who have been awarded more than $15 million in research funding since 2010 –– bring to IMB a wealth of experience in complex disease research.

Pregnancy couldn’t stop PhD

20 July 2016 | It is possible to combine family and a love of science. PhD graduate Rubbiya Ali looks back on everything she’s achieved at UQ, including mapping microalgae to help produce more efficient biofuels and having a son.

Tarantula venom turns the worm

19 July 2016 | Tarantula spider venom could become an unlikely ally in the war against sheep infections caused by nematode worms - a major cost for the international sheep industry. University of Queensland (UQ) Bachelor of Biomedical Science (honours) graduating student Samantha Nixon has been investigating compounds from tarantula venom as a potential treatment for sheep parasites which lead to huge economic losses for farmers. Samantha's honours year grew from a summer research project at UQ’s Institute for Molecular Bioscience (IMB) studying tarantula venoms.

Watch the live stream of Pain: Making it personal, 18 July 2016

18 July 2016 | Watch the live stream of our free community seminar, Pain: Making it personal, hosted by the IMB Centre for Pain Research.

IMB innovators shine at research awards

14 July 2016 | The quality of research performed at The University of Queensland was recognised at last night’s (13 July) National Health and Medical Research Council (NHMRC) Research Excellence Awards in Canberra. IMB's Professor Kirill Alexandrov was awarded the NHMRC's top-ranked development grant application, and Dr Joseph Powell was awarded the RD Wright Biomedical – Level 1 category of the Career Development Fellowship scheme and Commonwealth Minister’s Award for Excellence in Health and Medical Research.

Awards to help researcher unlock the secrets of DNA

14 July 2016 | UQ Institute for Molecular Bioscience’s Dr Joseph Powell has won the prestigious Commonwealth Minister’s Medal for Excellence in Health and Medical Research and the top-ranked RD Wright Career Development Fellowship.

Discovering new drugs to treat type 2 diabetes

13 July 2016 | IMB researchers are developing new drugs that target the underlying cause of diabetes and could be taken as tablets rather than injections.

Register now for ASMR Science in the Cinema

13 July 2016 | Please join the ASMR Queensland Branch for their upcoming Science in the Cinema event on 28 July 2016, supported by the IMB Centre for Pain Research.

IMB Seminar Series - Building organs in dishes: moving from party trick to medical application

Please join us on Friday 5 August 2016 from 12.30pm for our IMB Seminar Series with world-renowned kidney researcher Professor Melissa Little on 'Building organs in dishes: moving from party trick to medical application'.

Multimillion dollar biopharmaceutical centre to be established in Queensland

10 July 2016 | A $10 million biopharmaceutical initiative with strong industry support will be established at The University of Queensland to train the next generation of scientists and enhance Australia’s capabilities in the pharmaceutical sector.

IMB Seminar Series - Towards four-dimensional (eco)systems biology in the sea

Please join us on Friday 8 July 2016 from 12 noon for our IMB/2016 Winter School in Mathematical and Computational Biology Seminar with University of Hawaii's Professor Edward DeLong on 'Towards four-dimensional (eco)systems biology in the sea'.

Smartphone testing for Zika virus

30 June | 2016 Prototypes of a portable test for Zika virus and a range of other diseases, using just a microchip plugged into a smartphone, may be available by the end of 2016. The new test could be performed from the comfort of the patient’s own home according to Professor Kirill Alexandrov from the Institute for Molecular Bioscience (IMB) at The University of Queensland.

Deadly animals helping us understand pain

30 June 2016 | Toxins from snakes, spiders, jellyfish and scorpions are helping scientists to better understand how pain works, with the hope of managing chronic pain more effectively. Pain comes in many forms, requiring different treatments and often making it difficult to manage. Many painkillers have negative side effects including addiction, and for some the painkillers don’t even work.

Can algae fuel our future?

30 June 2016 | We can make biofuels with algae, but can we make them commercially viable? A University of Queensland (UQ) research team is working towards it – and Siemens, Neste Oil Corp, the Queensland Government and others have joined their quest.

UQ research hones in on new TB drugs

22 June 2016 | University of Queensland scientists are honing in on drug resistant tuberculosis (TB), in a project which could lead to new antibiotics. The UQ team, including IMB's Professor Rob Capon, has identified four new classes of compounds which act against TB bacteria, and hopes commercialisation activities could begin within two to three years.

Queensland researchers take the pain out of pain apps

20 June 2016 | Researchers from The University of Queensland are seeking public input as they develop a mobile app to help chronic pain sufferers and healthcare providers manage and treat pain. PainPal will help patients track their symptoms and medication while providing helpful information and support.

Unlocking secrets of the immune system could help combat colitis

17 June 2016 | Researchers have unlocked secrets of our ancient immune system, a major scientific advance which could help scientists and clinicians in the global fight against disease. An international team, including researchers from The University of Queensland, identified interactions between immune system pathways which could improve the treatment of diseases such as inflammatory bowel disease (IBD), which affects millions of people worldwide.

IMB staff shine at UQ awards night

15 June 2016 | IMB staff have been recognised for their outstanding contributions to the UQ community at the 2016 UQ Awards for Excellence ceremony, held on 9 June. IMB Research Grants Manager Michelle Foley received a UQ Award for Excellence in Service, and IMB’s Community for Antimicrobial Drug Discovery (CO-ADD) team received a UQ Award for Excellence in Innovation.

Queenslanders to battle cane toads

10 June 2016 | Queensland researchers have made a big leap forward in their quest to eradicate the billions of cane toads wreaking havoc on our native wildlife and habitats. Environmentally friendly cane toad traps – developed by a team of researchers from The University of Queensland and The University of Sydney – are one step closer to production, following an agreement between UQ and US-based pest control company, SpringStar Inc.

IMB scientist wins top Minister’s award

10 June 2016 | IMB Group Leader Dr Joseph Powell has been awarded the prestigious Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.

Spiders put the bite on irritable bowel syndrome pain

7 June 2016 | Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

Read our IMB Industry Impact newsletter

20 May 2016 | Read our latest industry newsletter to see how IMB is innovating for health and the environment, and translating our research to create change.

Innovating for agriculture | IMB spin-out starts clinical trials for IBD | Fighting cane toads with their own toxin

Pain: Making it Personal, free community event, 18 July

5 May 2016 | Join leading clinical pain scientist, Professor Lorimer Moseley, and IMB researchers as they discuss how the challenging and personal nature of pain is inspiring a new generation of patient-focused treatments for one of the most poorly understood and undertreated conditions in modern medicine.

Genome study offers new hope for children with rare diseases

10 May 2016 | An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.

IMB Seminar Series - Mining plants for new treatments for fungal diseases

Please join us on Friday 10 June 2016 from 12.30pm for our IMB Seminar with La Trobe University's Professor Marilyn Anderson AO on 'Mining plants for new treatments for fungal diseases'.

Growing medicines in plants

19 May 2016 | Taking medicine in the future could be as simple as eating a sunflower seed or drinking a cup of tea made from herbs grown in your own garden.

IMB Seminar Series - The reformation of molecular biology and evolution

Please join us on Friday 6 May 2016 from 12.30pm for our IMB Seminar with Garvan Institute of Medical Research Director Professor John Mattick AO on 'The reformation of molecular biology and evolution'.

UQ and African Network for Drugs and Diagnostics Innovation sign MOU to facilitate drug discovery in Africa

11 April 2016 | UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).

Australian and French researchers team up to discover new antibiotics

8 April 2016 | Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.

New research facility at the forefront of genomic engineering revolution

31 March 2016 | IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at UQ's St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.

Membrane Trafficking and Dynamics Symposium

30 March 2016 | You are invited to join us for a free half-day Membrane Trafficking and Dynamics Symposium on 18 April 2016 at IMB.

Breast cancer gene a key to unlocking new treatments

23 March 2016 | Researchers from The University of Queensland have identified a treatment target for aggressive forms of breast cancer.

IMB Seminar Series - Putting the balance back in diet: the nutritional geometry of health and ageing

Please join us on Friday 15 April 2016 from 12.30pm for our IMB Seminar with Charles Perkins Centre CEO Professor Stephen Simpson AC on 'Putting the balance back in diet: the nutritional geometry of health and ageing'.

World carbon dioxide emissions could rise more rapidly than expected

10 March 2016 | CO2 emissions and thus global warming could rise more quickly than expected, according to a new model by University of Queensland and Griffith University researchers.

Tarantula toxins show promise as future painkillers

28 February 2016 | Peptide toxins isolated from the venom of some animals -- such as the Peruvian green velvet tarantula -- can be beneficial when used to target neural receptors to reduce the sensation of pain.

What are rare diseases?

29 February 2016 | This year on Rare Disease Day, Associate Professor Carol Wicking, Director of the IMB Centre for Rare Diseases Research, explains what rare diseases are and why a co-ordinated approach to tackling rare diseases is needed.

UQ researchers unlocking mysteries of rare diseases

29 February 2016 | UQ researchers, including those at the IMB Centre for Rare Diseases Research, are working to find causes and treatments for some of the world’s rarest diseases – which collectively affect more than 1.2 million Australians.

Pancreatic cancer is four diseases, each with new treatment possibilities

25 February 2016 | An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

Virtual 'toolset' frees researchers from IT stress

23 February 2016 | The director of The University of Queensland’s Research Computing Centre has been named the iTnews Education Chief Information Officer of the Year.

Global influencers at IMB

IMB is home to some of the world’s most influential scientific minds, measured by Thomson Reuters Highly Cited Researchers index. New group leader Professor Grant Montgomery was named in this prestigious index.

IMB Seminar Series - Pain: Do you really get it?

Please join us on Friday 4 March 2016 from 12.30pm for our upcoming IMB Seminar Series event, where we will hear from the University of South Australia's Professor Lorimer Moseley on 'Pain: Do you really get it?'

Australian-European alignment for new antibiotics

9 February 2016 | The Community for Open Antimicrobial Drug Discovery (CO-ADD) at The University of Queensland’s Institute for Molecular Bioscience (IMB) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.

IMB Seminar Series - The Genes in our Food, 10 Feb

Please join us on 10 February 2016 from 12 noon for our first IMB Seminar Series event for 2016, where we will hear from current Director of Scotland's Roslin Institute (and former IMBer) Professor David Hume on 'Genes in our Food'.

Centre for Inflammation and Disease Research Annual Symposium

23 August 2016 | You are invited to join us for a free inflammation symposium on 25 November 2016, hosted by the IMB Centre for Inflammation and Disease Research.

On this site